𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen

✍ Scribed by Mahmoud R. Khoshnoud; Tommy Fornander; Hemming Johansson; Lars-Erik Rutqvist


Publisher
Springer US
Year
2007
Tongue
English
Weight
197 KB
Volume
107
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Risk of early recurrence among postmenop
✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi

Benefit and projected cost-effectiveness
✍ Bruce E. Hillner 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Abstract ## BACKGROUND Women who have estrogen receptor (ER)‐positive disease with postmenopausal onset and who receive tamoxifen as standard adjuvant treatment constitute the largest subgroup of patients with breast cancer. Recent data from the ATAC (‘Arimidex, Tamoxifen Alone or in Combinatio

The use of molecular assays to establish
✍ Frank A. Vicini; J. Vito Antonucci; Neal Goldstein; Michelle Wallace; Larry Kest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND. Results from numerous trials have indicated that breast‐conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad